Esperion Therapeutics (ESPR) Property, Plant & Equipment (Net) Growth (1y) (2013 - 2026)
Esperion Therapeutics (ESPR) Property, Plant & Equipment (Net) Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 1.76% |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | -13.67% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 8.08% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 4.82% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 41.30% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -4.09% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 4.48% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 33.24% |
| 10 | Esperion Therapeutics | 799.30 Mn | 643.14 Mn | 45.53 Mn | 36.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.40% |
| Dec 31, 2025 | 33.07% |
| Sep 30, 2025 | -37.72% |
| Jun 30, 2025 | -34.53% |
| Mar 31, 2025 | -14.93% |
| Sep 30, 2024 | 4,583.33% |
| Jun 30, 2024 | 859.38% |
| Mar 31, 2024 | 222.89% |
| Sep 30, 2023 | -97.66% |
| Jun 30, 2023 | -91.14% |
| Mar 31, 2023 | -83.76% |
| Dec 31, 2022 | -75.30% |
| Sep 30, 2022 | -68.67% |
| Jun 30, 2022 | -62.78% |
| Mar 31, 2022 | -54.50% |
| Dec 31, 2021 | -47.96% |
| Sep 30, 2021 | -41.97% |
| Jun 30, 2021 | -35.85% |
| Mar 31, 2021 | -22.39% |
| Dec 31, 2020 | 11.44% |